1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Prof Curdin Conrad: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TYK2 Inhibition in Paradoxical Psoriasis Deucravacitinib - Psoriasis | Phase 2 / Phase 3 | Terminated | Prof Curdin Conrad | 2 | 2024-06-20 | 2025-04-02 |
Psoriasis (1)
deucravacitinib (1)
Switzerland (1)